Ranbaxy forms pact with Teva to launch generic Lipitor in US
Teva Pharmaceuticals - Wikipedia
Teva to Pay $512 Million to Settle Suit Over Delay of Sleep Disorder Drug - The New York Times
Sun Pharma buys Ranbaxy from Japan's Daiichi
sandoz vs Teva Pharmaceutical Industries | Comparably
Ranbaxy launches generic Lipitor in Europe - Pharmafile
Case studies in Strategy: Teva | PPT
Threat of Generic Copycat Comes Back to Nip at Teva - WSJ
Teva's Ranbaxy Like Mess Builds Up in Mexico | Radio Compass Blog
Teva Pharmaceuticals | PPT
 "Ranbaxy loses 180-day exclusivity on heartburn drug in US")
Ranbaxy loses 180-day exclusivity on heartburn drug in US
Ranbaxy forms pact with Teva to launch generic Lipitor in US
Teva: Copaxone And Management Uncertainty May Be Hiding One Of The Last Bargains Around (NYSE:TEVA) | Seeking Alpha
Sun Pharma, Ranbaxy merger: Layoffs, supply synergy key to $250 mn savings | Mint
Diazepam 10 Mg Terapia Ranbaxy at Rs 1000/box in New Delhi | ID: 2852809113930
Delhi HC to decide on Whether Payments made by Ranbaxy India to TEVA Israel are taxable
Ranbaxy, Teva settle US anti-competition case | Mint
Pfizer, Inc. v. Teva Pharms. USA, Inc., 05-1331 (Fed. Cir. Nov. 22, 2005) (Prost, J.)
Ranbaxy-Sun Pharma merger to create world's fifth-largest generic drug firm - BusinessToday
Teva Pharmaceutical: Investment Opportunity During Fed Rate Hike (NYSE:TEVA) | Seeking Alpha
Ranbaxy gets approval to sell generic Lipitor - nj.com
Case studies in Strategy: Teva | PPT
Ranbaxy, Teva settle US antitrust claims - The Hindu BusinessLine
Ranbaxy vs Teva Pharmaceuticals | Comparably
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals Ltd: A Global Leader in Generic Drugs | PDF | Generic Drug | Novartis
Fortune India: Business News, Strategy, Finance and Corporate Insight
